The Glycine Encephalopathy Gene Panel by NGS analyzes key genes associated with nonketotic hyperglycinemia, a severe metabolic disorder caused by impaired glycine breakdown. Using an EDTA blood sample, this test detects pathogenic variants affecting the glycine cleavage system. Metropolis Healthcare performs high-precision next-generation sequencing to ensure accurate diagnosis and meaningful clinical interpretation. The results support early detection, treatment planning, and genetic counseling for families.
Price:
Rs. 19,950.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0199
Frequently Asked Questions (FAQ's):
What does the Glycine Encephalopathy Gene Panel include at Metropolis Healthcare?
It examines multiple genes involved in the glycine cleavage system using advanced next-generation sequencing.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare extracts DNA from EDTA blood and sequences relevant genes with high-accuracy NGS platforms.
Who should consider taking this test at Metropolis Healthcare?
Newborns or individuals with seizures, lethargy, developmental delays, or suspected nonketotic hyperglycinemia may benefit from this panel.
What sample is required for this test at Metropolis Healthcare?
A standard EDTA blood sample is needed for accurate DNA extraction and sequencing.
How long does Metropolis Healthcare take to deliver results?
Turnaround time varies with sequencing and analysis steps, and results are shared promptly after evaluation.
Why choose Metropolis Healthcare for this genetic panel?
Metropolis Healthcare ensures comprehensive gene coverage, strict quality control, and clinically focused interpretation.
Does Metropolis Healthcare provide guidance after the test results?
Yes, expert genetic insights accompany the report to support clinicians in diagnosis and management planning.
Is this test suitable for infants at Metropolis Healthcare?
Yes, the panel is appropriate for newborns, children, and adults when glycine encephalopathy is suspected